<!DOCTYPE html>
<html style="font-size: 16px;" lang="en"><head>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <meta name="keywords" content="Hello, I’m John., Design and Concept&nbsp;Development, My Works, Expertise, Profile, Pricing Table, Nam ultrices ultrices nec tortor pulvinar esteras loremips est orem., Follow us, Contact Me">
    <meta name="description" content="">
    <title>Home</title>
    <link rel="stylesheet" href="nicepage.css" media="screen">
<link rel="stylesheet" href="Home.css" media="screen">
    <script class="u-script" type="text/javascript" src="jquery.js" defer=""></script>
    <script class="u-script" type="text/javascript" src="nicepage.js" defer=""></script>
    <meta name="generator" content="Nicepage 4.13.4, nicepage.com">
    <link id="u-theme-google-font" rel="stylesheet" href="https://fonts.googleapis.com/css?family=Oswald:200,300,400,500,600,700|Open+Sans:300,300i,400,400i,500,500i,600,600i,700,700i,800,800i">
    <link id="u-page-google-font" rel="stylesheet" href="https://fonts.googleapis.com/css?family=Oswald:200,300,400,500,600,700|PT+Sans:400,400i,700,700i">
    
    
    
    
    
    
    
    <script type="application/ld+json">{
		"@context": "http://schema.org",
		"@type": "Organization",
		"name": ""
}</script>
    <meta name="theme-color" content="#0063b1">
    <meta property="og:title" content="Home">
    <meta property="og:type" content="website">
  </head>
  <body data-home-page="Home.html" data-home-page-title="Home" class="u-body u-xl-mode"> 
    <section class="u-align-center u-clearfix u-palette-4-base u-valign-middle-xs u-valign-top-md u-valign-top-sm u-section-1" id="sec-d430">
      <div class="u-clearfix u-sheet u-valign-middle-md u-valign-middle-sm u-valign-middle-xs u-sheet-1">
        <div class="u-clearfix u-gutter-0 u-layout-wrap u-layout-wrap-1">
          <div class="u-gutter-0 u-layout">
            <div class="u-layout-row">
              <div class="u-container-style u-image u-layout-cell u-size-30 u-image-1" data-image-width="1920" data-image-height="1888">
                <div class="u-container-layout u-valign-bottom u-container-layout-1"></div>
              </div>
              <div class="u-align-left-lg u-align-left-md u-align-left-xl u-container-style u-layout-cell u-shape-rectangle u-size-30 u-white u-layout-cell-2">
                <div class="u-container-layout u-valign-bottom-lg u-container-layout-2">
                  <h1 class="u-align-center-sm u-align-center-xs u-custom-font u-font-oswald u-text u-text-1">Researching to defeat cancer</h1>
                  <h6 class="u-align-left-sm u-align-left-xs u-custom-font u-font-pt-sans u-text u-text-default u-text-palette-4-base u-text-2">Pablo Lara<br>Postdoctoral researcher<br>
                  </h6>
                  <p class="u-align-left-sm u-align-left-xs u-text u-text-grey-50 u-text-3">Translational Nanomaterials and Imaging (TNI) group<br>Leiden University Medical Center<br>The Netherlands
                  </p>
                  <p class="u-text u-text-4"><span class="u-icon u-text-palette-4-base u-icon-1"><svg class="u-svg-content" viewBox="0 0 512 512" x="0px" y="0px" style="width: 1em; height: 1em;"><g><g><polygon points="339.392,258.624 512,367.744 512,144.896   "></polygon>
</g>
</g><g><g><polygon points="0,144.896 0,367.744 172.608,258.624   "></polygon>
</g>
</g><g><g><path d="M480,80H32C16.032,80,3.36,91.904,0.96,107.232L256,275.264l255.04-168.032C508.64,91.904,495.968,80,480,80z"></path>
</g>
</g><g><g><path d="M310.08,277.952l-45.28,29.824c-2.688,1.76-5.728,2.624-8.8,2.624c-3.072,0-6.112-0.864-8.8-2.624l-45.28-29.856    L1.024,404.992C3.488,420.192,16.096,432,32,432h448c15.904,0,28.512-11.808,30.976-27.008L310.08,277.952z"></path>
</g>
</g></svg><img></span>&nbsp;Email: <a href="mailto:info@youremailidhere.com" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-4-base u-btn-1">p.lara_arenas@lumc.nl</a>
                  </p>
                  <p class="u-align-left-sm u-align-left-xs u-text u-text-5"><span class="u-icon u-text-palette-4-base u-icon-2"><svg class="u-svg-content" viewBox="0 0 512 512" x="0px" y="0px" style="width: 1em; height: 1em;"><g><g><path d="M256,0C161.896,0,85.333,76.563,85.333,170.667c0,28.25,7.063,56.26,20.49,81.104L246.667,506.5    c1.875,3.396,5.448,5.5,9.333,5.5s7.458-2.104,9.333-5.5l140.896-254.813c13.375-24.76,20.438-52.771,20.438-81.021    C426.667,76.563,350.104,0,256,0z M256,256c-47.052,0-85.333-38.281-85.333-85.333c0-47.052,38.281-85.333,85.333-85.333    s85.333,38.281,85.333,85.333C341.333,217.719,303.052,256,256,256z"></path>
</g>
</g></svg><img></span>&nbsp;Address: Albinusdreef 2, 2333 ZA Leiden
                  </p>
                  <p class="u-text u-text-6"><span class="u-file-icon u-icon u-icon-3"><img src="images/ORCID_iD.svg.png" alt=""></span>&nbsp;ORCID:&nbsp;0000-0001-7791-647X
                  </p>
                  <div class="u-social-icons u-spacing-10 u-social-icons-1">
                    <a class="u-social-url" title="Linkedin" target="_blank" href="https://www.linkedin.com/feed/"><span class="u-file-icon u-icon u-social-facebook u-social-icon u-icon-4"><img src="images/174857.png" alt=""></span>
                    </a>
                    <a class="u-social-url" title="researchgate" target="_blank" href="https://www.researchgate.net/profile/Pablo-Lara-15"><span class="u-file-icon u-icon u-social-icon u-social-twitter u-icon-5"><img src="images/png-clipart-researchgate-free-university-of-berlin-science-walkden-blue-text-thumbnail.png" alt=""></span>
                    </a>
                    <a class="u-social-url" title="instagram" target="_blank" href="https://scholar.google.com/citations?user=c8iaExAAAAAJ&amp;hl=nl"><span class="u-file-icon u-icon u-social-icon u-social-instagram u-icon-6"><img src="images/352-3521620_facebook-twitter-repec-linkedin-research-gate-google-logo-google-scholar.png" alt=""></span>
                    </a>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>
    <section class="u-carousel u-slide u-block-30d8-1" id="carousel_b4d9" data-interval="5000" data-u-ride="carousel">
      <ol class="u-carousel-indicators u-block-30d8-5">
        <li data-u-target="#carousel_b4d9" class="u-active u-grey-30" data-u-slide-to="0"></li>
        <li data-u-target="#carousel_b4d9" class="u-grey-30" data-u-slide-to="1"></li>
        <li data-u-target="#carousel_b4d9" class="u-grey-30" data-u-slide-to="2"></li>
      </ol>
      <div class="u-carousel-inner" role="listbox">
        <div class="u-active u-align-center u-carousel-item u-clearfix u-palette-3-light-3 u-section-2-1">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-default u-title u-text-1">Participation in EU-talentOn 2022</h1>
            <img class="u-image u-image-default u-image-1" src="images/Capturadepantalla2022-09-02203439.jpg" alt="" data-image-width="1600" data-image-height="566">
            <a href="https://talenton.eu/teams/" class="u-border-2 u-border-grey-dark-1 u-btn u-btn-round u-button-style u-radius-50 u-btn-1">Read More</a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-grey-80 u-section-2-2">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-default u-title u-text-1"> Participation in EU-talentOn ​2022</h1>
            <p class="u-large-text u-text u-text-variant u-text-2"> Between September 14 and 18, I participated in the EU TalentOn in Leiden European City of Science 2022 . Teams were challenged&nbsp;to come up with the best scientific solutions to societal challenges. Our team was awarded with a first place in a pitch contest and a 3rd place in the cancer challenge.<br>
              <br>
              <br>
            </p>
            <a href="https://talenton.eu/" class="u-border-2 u-border-grey-dark-1 u-btn u-btn-round u-button-style u-radius-50 u-white u-btn-1">Read More</a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-grey-80 u-section-2-3">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-title u-text-1"> Participation in EU-talentOn ​2022</h1>
            <img class="u-image u-image-default u-image-1" src="images/WhatsAppImage2022-09-18at7.03.11PM.jpeg" alt="" data-image-width="1536" data-image-height="2048">
            <img class="u-image u-image-default u-image-2" src="images/WhatsAppImage2022-09-18at7.02.57PM.jpeg" alt="" data-image-width="2048" data-image-height="1536">
          </div>
        </div>
      </div>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-prev u-text-grey-30 u-block-30d8-3" href="#carousel_b4d9" role="button" data-u-slide="prev">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M145.188,238.575l215.5-215.5c5.3-5.3,5.3-13.8,0-19.1s-13.8-5.3-19.1,0l-225.1,225.1c-5.3,5.3-5.3,13.8,0,19.1l225.1,225
                    c2.6,2.6,6.1,4,9.5,4s6.9-1.3,9.5-4c5.3-5.3,5.3-13.8,0-19.1L145.188,238.575z"></path></svg>
        </span>
        <span class="sr-only">Previous</span>
      </a>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-next u-text-grey-30 u-block-30d8-4" href="#carousel_b4d9" role="button" data-u-slide="next">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M360.731,229.075l-225.1-225.1c-5.3-5.3-13.8-5.3-19.1,0s-5.3,13.8,0,19.1l215.5,215.5l-215.5,215.5
                    c-5.3,5.3-5.3,13.8,0,19.1c2.6,2.6,6.1,4,9.5,4c3.4,0,6.9-1.3,9.5-4l225.1-225.1C365.931,242.875,365.931,234.275,360.731,229.075z"></path></svg>
        </span>
        <span class="sr-only">Next</span>
      </a>
    </section>
    <section class="u-carousel u-slide u-block-fe1f-1" id="carousel_f585" data-interval="5000" data-u-ride="carousel">
      <ol class="u-carousel-indicators u-block-fe1f-5">
        <li data-u-target="#carousel_f585" data-u-slide-to="0" class="u-active u-grey-30"></li>
        <li data-u-target="#carousel_f585" class="u-grey-30" data-u-slide-to="1" style=""></li>
      </ol>
      <div class="u-carousel-inner" role="listbox" style="">
        <div class="u-active u-carousel-item u-clearfix u-palette-4-base u-section-3-1">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h2 class="u-text u-text-1">Board member of the YFN <span style="font-weight: 700;"></span>
            </h2>
            <img class="u-image u-image-default u-image-1" src="images/yfn-do-blauw-detail-logo.png" alt="" data-image-width="400" data-image-height="275">
            <h4 class="u-text u-text-2">At LUMC's Young Faculty Network (YFN) we aim to connect postdoctoral fellows, senior researchers, and assistant and associate professors within the Leiden University Medical Center. We provide a platform to exchange knowledge, ideas and experiences by organizing networking events and symposia on topics relevant to young faculty. In doing so, YFN promotes research and career opportunities for (fundamental) scientists within the university medical center.</h4>
            <a href="https://www.linkedin.com/groups/4764960/" class="u-btn u-button-style u-none u-text-hover-palette-2-base u-btn-1">Read More&nbsp;<span class="u-icon u-text-palette-1-base"><svg class="u-svg-content" viewBox="0 -32 426.66667 426" style="width: 1em; height: 1em;"><path d="m213.332031 181.667969c0 4.265625-1.277343 8.53125-3.625 11.730469l-106.667969 160c-3.839843 5.761718-10.238281 9.601562-17.707031 9.601562h-64c-11.730469 0-21.332031-9.601562-21.332031-21.332031 0-4.269531 1.28125-8.535157 3.625-11.734375l98.773438-148.265625-98.773438-148.269531c-2.34375-3.199219-3.625-7.464844-3.625-11.730469 0-11.734375 9.601562-21.335938 21.332031-21.335938h64c7.46875 0 13.867188 3.839844 17.707031 9.601563l106.667969 160c2.347657 3.199218 3.625 7.464844 3.625 11.734375zm0 0"></path><path d="m426.667969 181.667969c0 4.265625-1.28125 8.53125-3.628907 11.730469l-106.664062 160c-3.839844 5.761718-10.242188 9.601562-17.707031 9.601562h-64c-11.734375 0-21.335938-9.601562-21.335938-21.332031 0-4.269531 1.28125-8.535157 3.628907-11.734375l98.773437-148.265625-98.773437-148.269531c-2.347657-3.199219-3.628907-7.464844-3.628907-11.730469 0-11.734375 9.601563-21.335938 21.335938-21.335938h64c7.464843 0 13.867187 3.839844 17.707031 9.601563l106.664062 160c2.347657 3.199218 3.628907 7.464844 3.628907 11.734375zm0 0"></path></svg><img></span>
            </a>
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-palette-4-base u-section-3-2">
          <div class="u-clearfix u-sheet u-valign-middle-xl u-sheet-1">
            <img class="u-image u-image-default u-image-1" src="images/YFNboardimage.jpg" alt="" data-image-width="1920" data-image-height="1080">
          </div>
        </div>
      </div>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-prev u-text-grey-30 u-block-fe1f-3" href="#carousel_f585" role="button" data-u-slide="prev">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M145.188,238.575l215.5-215.5c5.3-5.3,5.3-13.8,0-19.1s-13.8-5.3-19.1,0l-225.1,225.1c-5.3,5.3-5.3,13.8,0,19.1l225.1,225
                    c2.6,2.6,6.1,4,9.5,4s6.9-1.3,9.5-4c5.3-5.3,5.3-13.8,0-19.1L145.188,238.575z"></path></svg>
        </span>
        <span class="sr-only">Previous</span>
      </a>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-next u-text-grey-30 u-block-fe1f-4" href="#carousel_f585" role="button" data-u-slide="next">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M360.731,229.075l-225.1-225.1c-5.3-5.3-13.8-5.3-19.1,0s-5.3,13.8,0,19.1l215.5,215.5l-215.5,215.5
                    c-5.3,5.3-5.3,13.8,0,19.1c2.6,2.6,6.1,4,9.5,4c3.4,0,6.9-1.3,9.5-4l225.1-225.1C365.931,242.875,365.931,234.275,360.731,229.075z"></path></svg>
        </span>
        <span class="sr-only">Next</span>
      </a>
    </section>
    <section class="u-carousel u-slide u-block-48f6-1" id="carousel_5a10" data-interval="5000" data-u-ride="carousel">
      <ol class="u-absolute-hcenter-md u-absolute-hcenter-sm u-absolute-hcenter-xs u-carousel-indicators u-block-48f6-5">
        <li data-u-target="#carousel_5a10" class="u-active u-grey-30" data-u-slide-to="0"></li>
        <li data-u-target="#carousel_5a10" class="u-grey-30" data-u-slide-to="1"></li>
        <li data-u-target="#carousel_5a10" class="u-grey-30" data-u-slide-to="2"></li>
        <li data-u-target="#carousel_5a10" class="u-grey-30" data-u-slide-to="3"></li>
        <li data-u-target="#carousel_5a10" class="u-grey-30" data-u-slide-to="4"></li>
        <li data-u-target="#carousel_5a10" class="u-grey-30" data-u-slide-to="5"></li>
      </ol>
      <div class="u-carousel-inner" role="listbox">
        <div class="u-active u-align-center u-carousel-item u-clearfix u-section-4-1">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <h2 class="u-text u-text-1">How can we increase treatment selectivity against cancer?</h2>
            <img class="u-expanded-width-xs u-image u-image-default u-image-1" src="images/Capturadepantalla2022-09-02232902.jpg" alt="" data-image-width="1450" data-image-height="836">
            <p class="u-text u-text-2"> One of key problems of
metastasis is the lack of drugs able to target the small secondary tumor nodules.&nbsp; My study&nbsp;
demonstrated that melanoma extracellular vesicles (EVs) act as natural
nanoparticles and have a preferential uptake towards melanoma metastasis. The publication describes the potential of EVs as trojan horses for cancer therapeutics </p>
            <a href="https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-020-0573-0" class="u-btn u-button-style u-none u-text-hover-palette-1-base u-text-palette-2-base u-btn-1">ChecK this link to know more&nbsp;&nbsp;<span class="u-icon u-text-palette-2-base u-icon-1"><svg class="u-svg-content" viewBox="0 0 412.72 412.72" x="0px" y="0px" style="width: 1em; height: 1em;"><path d="M404.72,82.944c-0.027,0-0.054,0-0.08,0h0h-27.12v-9.28c0.146-3.673-2.23-6.974-5.76-8    c-18.828-4.934-38.216-7.408-57.68-7.36c-32,0-75.6,7.2-107.84,40c-32-33.12-75.92-40-107.84-40    c-19.464-0.048-38.852,2.426-57.68,7.36c-3.53,1.026-5.906,4.327-5.76,8v9.2H8c-4.418,0-8,3.582-8,8v255.52c0,4.418,3.582,8,8,8    c1.374-0.004,2.724-0.362,3.92-1.04c0.8-0.4,80.8-44.16,192.48-16h1.2h0.72c0.638,0.077,1.282,0.077,1.92,0    c112-28.4,192,15.28,192.48,16c2.475,1.429,5.525,1.429,8,0c2.46-1.42,3.983-4.039,4-6.88V90.944    C412.72,86.526,409.139,82.944,404.72,82.944z M16,333.664V98.944h19.12v200.64c-0.05,4.418,3.491,8.04,7.909,8.09    c0.432,0.005,0.864-0.025,1.291-0.09c16.55-2.527,33.259-3.864,50-4c23.19-0.402,46.283,3.086,68.32,10.32    C112.875,307.886,62.397,314.688,16,333.664z M94.32,287.664c-14.551,0.033-29.085,0.968-43.52,2.8V79.984    c15.576-3.47,31.482-5.241,47.44-5.28c29.92,0,71.2,6.88,99.84,39.2l0.24,199.28C181.68,302.304,149.2,287.664,94.32,287.664z     M214.32,113.904c28.64-32,69.92-39.2,99.84-39.2c15.957,0.047,31.863,1.817,47.44,5.28v210.48    c-14.354-1.849-28.808-2.811-43.28-2.88c-54.56,0-87.12,14.64-104,25.52V113.904z M396.64,333.664    c-46.496-19.028-97.09-25.831-146.96-19.76c22.141-7.26,45.344-10.749,68.64-10.32c16.846,0.094,33.663,1.404,50.32,3.92    c4.368,0.663,8.447-2.341,9.11-6.709c0.065-0.427,0.095-0.859,0.09-1.291V98.944h19.12L396.64,333.664z"></path></svg><img></span>
            </a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-4-2">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <img class="u-expanded-width-sm u-expanded-width-xs u-image u-image-default u-image-1" src="images/Capturadepantalla2022-09-02233102.jpg" alt="" data-image-width="1158" data-image-height="682">
            <h3 class="u-text u-text-1">Increasing antitumoral efficacy by reprograming cancer cells and their surrounding enviorment</h3>
            <p class="u-large-text u-text u-text-variant u-text-2"> Modulating the
physiological state of EVs for optimal antitumoral efficacy is one of the key
concepts of my research. In my research I evaluate the different antitumoral capacity of extracellular vesicles (EVs) according to their physiological states. For example, EVs from activated immune cells
were able to induce Dendric cell maturation, reduce cell growth and promote a
vaccine-like cancer immunological memory after PDT. </p>
            <a href="https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-022-01448-z" class="u-btn u-button-style u-none u-text-hover-palette-1-base u-text-palette-2-base u-btn-1">Check this link for more information&nbsp;<span class="u-icon u-text-palette-2-base u-icon-1"><svg class="u-svg-content" viewBox="0 0 412.72 412.72" x="0px" y="0px" style="width: 1em; height: 1em;"><path d="M404.72,82.944c-0.027,0-0.054,0-0.08,0h0h-27.12v-9.28c0.146-3.673-2.23-6.974-5.76-8    c-18.828-4.934-38.216-7.408-57.68-7.36c-32,0-75.6,7.2-107.84,40c-32-33.12-75.92-40-107.84-40    c-19.464-0.048-38.852,2.426-57.68,7.36c-3.53,1.026-5.906,4.327-5.76,8v9.2H8c-4.418,0-8,3.582-8,8v255.52c0,4.418,3.582,8,8,8    c1.374-0.004,2.724-0.362,3.92-1.04c0.8-0.4,80.8-44.16,192.48-16h1.2h0.72c0.638,0.077,1.282,0.077,1.92,0    c112-28.4,192,15.28,192.48,16c2.475,1.429,5.525,1.429,8,0c2.46-1.42,3.983-4.039,4-6.88V90.944    C412.72,86.526,409.139,82.944,404.72,82.944z M16,333.664V98.944h19.12v200.64c-0.05,4.418,3.491,8.04,7.909,8.09    c0.432,0.005,0.864-0.025,1.291-0.09c16.55-2.527,33.259-3.864,50-4c23.19-0.402,46.283,3.086,68.32,10.32    C112.875,307.886,62.397,314.688,16,333.664z M94.32,287.664c-14.551,0.033-29.085,0.968-43.52,2.8V79.984    c15.576-3.47,31.482-5.241,47.44-5.28c29.92,0,71.2,6.88,99.84,39.2l0.24,199.28C181.68,302.304,149.2,287.664,94.32,287.664z     M214.32,113.904c28.64-32,69.92-39.2,99.84-39.2c15.957,0.047,31.863,1.817,47.44,5.28v210.48    c-14.354-1.849-28.808-2.811-43.28-2.88c-54.56,0-87.12,14.64-104,25.52V113.904z M396.64,333.664    c-46.496-19.028-97.09-25.831-146.96-19.76c22.141-7.26,45.344-10.749,68.64-10.32c16.846,0.094,33.663,1.404,50.32,3.92    c4.368,0.663,8.447-2.341,9.11-6.709c0.065-0.427,0.095-0.859,0.09-1.291V98.944h19.12L396.64,333.664z"></path></svg><img></span>
            </a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-4-3">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <img class="u-expanded-width-sm u-expanded-width-xs u-image u-image-default u-image-1" src="images/KWFprogressreport2022010222.jpg" alt="" data-image-width="2111" data-image-height="1233">
            <h6 class="u-text u-text-1">
              <a name="_Hlk93424911" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-1">Using state of art technology for simultaneus treatment and imaging of cancer</a>
            </h6>
            <p class="u-align-justify u-large-text u-text u-text-variant u-text-2">Thanks to the funding obtained from the Dutch society for cancer control (KWF), I aim to develop a novel drug
delivery platform using theranostic extracellular vesicles (EVs) for <b>simultaneous immunotherapy, tumor
targeting, photodynamic therapy (PDT) and imaging of cancer</b>. To achieve
this,<b>&nbsp;a smart nanosystem is created using EVs, tumor antigens,&nbsp; photosensitizers (PS)</b> and <b>upconversion nanoparticles (UCNPs) .</b>
            </p>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-4-4">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <img class="u-image u-image-default u-image-1" src="images/Capturadepantalla2022-09-02233856.jpg" alt="" data-image-width="1007" data-image-height="972">
            <h3 class="u-align-justify u-text u-text-1">Using natural nanoparticles produced by our own cells to fight against cancer and other diseases</h3>
            <p class="u-align-justify u-large-text u-text u-text-variant u-text-2"> Extracelluar vesicles are natural nanoparticles, released by most cells which have great therapeutic potential. My research focus in developing &nbsp;strategies to isolate this particules and modulate thier properties for targeting and immunotherapy&nbsp;</p>
            <a href="https://www.mdpi.com/1999-4923/12/11/1022" class="u-btn u-button-style u-none u-text-hover-palette-1-base u-text-palette-2-base u-btn-1">Link to know more&nbsp;<span class="u-icon u-text-palette-2-base u-icon-1"><svg class="u-svg-content" viewBox="0 0 412.72 412.72" x="0px" y="0px" style="width: 1em; height: 1em;"><path d="M404.72,82.944c-0.027,0-0.054,0-0.08,0h0h-27.12v-9.28c0.146-3.673-2.23-6.974-5.76-8    c-18.828-4.934-38.216-7.408-57.68-7.36c-32,0-75.6,7.2-107.84,40c-32-33.12-75.92-40-107.84-40    c-19.464-0.048-38.852,2.426-57.68,7.36c-3.53,1.026-5.906,4.327-5.76,8v9.2H8c-4.418,0-8,3.582-8,8v255.52c0,4.418,3.582,8,8,8    c1.374-0.004,2.724-0.362,3.92-1.04c0.8-0.4,80.8-44.16,192.48-16h1.2h0.72c0.638,0.077,1.282,0.077,1.92,0    c112-28.4,192,15.28,192.48,16c2.475,1.429,5.525,1.429,8,0c2.46-1.42,3.983-4.039,4-6.88V90.944    C412.72,86.526,409.139,82.944,404.72,82.944z M16,333.664V98.944h19.12v200.64c-0.05,4.418,3.491,8.04,7.909,8.09    c0.432,0.005,0.864-0.025,1.291-0.09c16.55-2.527,33.259-3.864,50-4c23.19-0.402,46.283,3.086,68.32,10.32    C112.875,307.886,62.397,314.688,16,333.664z M94.32,287.664c-14.551,0.033-29.085,0.968-43.52,2.8V79.984    c15.576-3.47,31.482-5.241,47.44-5.28c29.92,0,71.2,6.88,99.84,39.2l0.24,199.28C181.68,302.304,149.2,287.664,94.32,287.664z     M214.32,113.904c28.64-32,69.92-39.2,99.84-39.2c15.957,0.047,31.863,1.817,47.44,5.28v210.48    c-14.354-1.849-28.808-2.811-43.28-2.88c-54.56,0-87.12,14.64-104,25.52V113.904z M396.64,333.664    c-46.496-19.028-97.09-25.831-146.96-19.76c22.141-7.26,45.344-10.749,68.64-10.32c16.846,0.094,33.663,1.404,50.32,3.92    c4.368,0.663,8.447-2.341,9.11-6.709c0.065-0.427,0.095-0.859,0.09-1.291V98.944h19.12L396.64,333.664z"></path></svg><img></span>
            </a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-4-5">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <img class="u-image u-image-default u-image-1" src="images/znpc2022.jpg" alt="" data-image-width="869" data-image-height="1315">
            <h4 class="u-text u-text-1">INCREASING THE THERAPEUTIC POTENTIAL OF PHOTODYNAMIC THERAPY</h4>
            <p class="u-large-text u-text u-text-variant u-text-2">Photodynamic therapy (PDT) is a promising and clinically approved method for the treatment of cancer. However, the efficacy of PDT is often limited by the poor selectivity and distribution of the photosensitizers (PS) toward the malignant tumors, resulting in prolonged periods of skin photosensitivity.<br>
              <br>I developed a strategy to increase the tumor distribution, selectivity, and efficacy of lipophilic PS by their stabilization in purified, naturally secreted extracellular vesicles (EVs)
            </p>
            <a href="https://www.mdpi.com/1999-4923/13/10/1547" class="u-btn u-button-style u-none u-text-hover-palette-1-base u-text-palette-2-base u-btn-1">Link FOR MORE INFORMATIOn&nbsp;<span class="u-icon u-text-palette-2-base u-icon-1"><svg class="u-svg-content" viewBox="0 0 412.72 412.72" x="0px" y="0px" style="width: 1em; height: 1em;"><path d="M404.72,82.944c-0.027,0-0.054,0-0.08,0h0h-27.12v-9.28c0.146-3.673-2.23-6.974-5.76-8    c-18.828-4.934-38.216-7.408-57.68-7.36c-32,0-75.6,7.2-107.84,40c-32-33.12-75.92-40-107.84-40    c-19.464-0.048-38.852,2.426-57.68,7.36c-3.53,1.026-5.906,4.327-5.76,8v9.2H8c-4.418,0-8,3.582-8,8v255.52c0,4.418,3.582,8,8,8    c1.374-0.004,2.724-0.362,3.92-1.04c0.8-0.4,80.8-44.16,192.48-16h1.2h0.72c0.638,0.077,1.282,0.077,1.92,0    c112-28.4,192,15.28,192.48,16c2.475,1.429,5.525,1.429,8,0c2.46-1.42,3.983-4.039,4-6.88V90.944    C412.72,86.526,409.139,82.944,404.72,82.944z M16,333.664V98.944h19.12v200.64c-0.05,4.418,3.491,8.04,7.909,8.09    c0.432,0.005,0.864-0.025,1.291-0.09c16.55-2.527,33.259-3.864,50-4c23.19-0.402,46.283,3.086,68.32,10.32    C112.875,307.886,62.397,314.688,16,333.664z M94.32,287.664c-14.551,0.033-29.085,0.968-43.52,2.8V79.984    c15.576-3.47,31.482-5.241,47.44-5.28c29.92,0,71.2,6.88,99.84,39.2l0.24,199.28C181.68,302.304,149.2,287.664,94.32,287.664z     M214.32,113.904c28.64-32,69.92-39.2,99.84-39.2c15.957,0.047,31.863,1.817,47.44,5.28v210.48    c-14.354-1.849-28.808-2.811-43.28-2.88c-54.56,0-87.12,14.64-104,25.52V113.904z M396.64,333.664    c-46.496-19.028-97.09-25.831-146.96-19.76c22.141-7.26,45.344-10.749,68.64-10.32c16.846,0.094,33.663,1.404,50.32,3.92    c4.368,0.663,8.447-2.341,9.11-6.709c0.065-0.427,0.095-0.859,0.09-1.291V98.944h19.12L396.64,333.664z"></path></svg><img></span>
            </a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-4-6">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h3 class="u-text u-text-1">TREATING CANCER BY EXTERNAL LIGHT IRRADIATION</h3>
            <img class="u-expanded-width-sm u-expanded-width-xs u-image u-image-default u-image-1" src="images/Presentation211.jpg" alt="" data-image-width="5514" data-image-height="2420">
            <p class="u-large-text u-text u-text-variant u-text-2">We aim to control by external stimulation, the release of drugs that are co-encapsulated with metallic nanoparticles. In this way, the management and control of these systems will considerably improve therapeutic efficiency and reduce adverse and collateral effects, resulting in greater acceptance by patients.</p>
            <a href="https://pubmed.ncbi.nlm.nih.gov/29783629/" class="u-border-2 u-border-grey-dark-1 u-btn u-btn-round u-button-style u-radius-50 u-btn-1">Read More</a>
          </div>
        </div>
      </div>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-prev u-text-grey-30 u-block-48f6-3" href="#carousel_5a10" role="button" data-u-slide="prev">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M145.188,238.575l215.5-215.5c5.3-5.3,5.3-13.8,0-19.1s-13.8-5.3-19.1,0l-225.1,225.1c-5.3,5.3-5.3,13.8,0,19.1l225.1,225
                    c2.6,2.6,6.1,4,9.5,4s6.9-1.3,9.5-4c5.3-5.3,5.3-13.8,0-19.1L145.188,238.575z"></path></svg>
        </span>
        <span class="sr-only">Previous</span>
      </a>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-next u-text-grey-30 u-block-48f6-4" href="#carousel_5a10" role="button" data-u-slide="next">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M360.731,229.075l-225.1-225.1c-5.3-5.3-13.8-5.3-19.1,0s-5.3,13.8,0,19.1l215.5,215.5l-215.5,215.5
                    c-5.3,5.3-5.3,13.8,0,19.1c2.6,2.6,6.1,4,9.5,4c3.4,0,6.9-1.3,9.5-4l225.1-225.1C365.931,242.875,365.931,234.275,360.731,229.075z"></path></svg>
        </span>
        <span class="sr-only">Next</span>
      </a>
    </section>
    <section class="u-carousel u-slide u-block-8612-1" id="carousel_b0d3" data-interval="5000" data-u-ride="carousel">
      <ol class="u-absolute-hcenter-lg u-absolute-hcenter-md u-absolute-hcenter-xl u-carousel-indicators u-block-8612-5">
        <li data-u-target="#carousel_b0d3" class="u-active u-grey-30" data-u-slide-to="0"></li>
        <li data-u-target="#carousel_b0d3" class="u-grey-30" data-u-slide-to="1"></li>
        <li data-u-target="#carousel_b0d3" class="u-grey-30" data-u-slide-to="2"></li>
      </ol>
      <div class="u-carousel-inner" role="listbox" style="">
        <div class="u-active u-carousel-item u-clearfix u-section-5-1">
          <div class="u-align-left u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-default u-text-1"><b>Knowledge utilization</b>
            </h1>
            <h3 class="u-text u-text-default-lg u-text-default-md u-text-default-sm u-text-default-xl u-text-2">How I help bringing research into the market</h3>
            <img class="u-expanded-width-md u-expanded-width-xs u-image u-image-default u-image-1" src="images/Presentation1.jpg" alt="" data-image-width="3951" data-image-height="1591">
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-5-2">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-default u-text-1"><b></b>
            </h1>
            <h3 class="u-text u-text-2">NANOFIX: ​SCIENTIFIC STUDIES &amp; TECHNOLOGICAL DEVELOPMENT</h3>
            <h1 class="u-text u-text-default u-title u-text-3">&nbsp;</h1>
            <p class="u-large-text u-text u-text-variant u-text-4">There are more than 15 thousand scientific studies that prove the functionality of curcumin. Only 3% of a kilo of turmeric corresponds to Curcumin, the rest does not have scientifically proven properties.&nbsp; Furthermore,&nbsp;<b>the oral bioavailability of curcumin is low</b>&nbsp;due to a relatively low absorption by small intestine<br>At Nanofix we take this laboratory technology and bring it to a simple and easy-to-take food product, managing to solubilize the molecules and transport the nanoparticles in a unique nanometer-sized vehicle (&lt;220 nanometers) to achieve the maximum absorption today available on the market. Download our Study (&nbsp;<a href="https://tiendananofix.cl/wp-content/uploads/2021/09/Paper-Nanoemulsion-Nanoscale-Magazine.pdf" class="u-active-none u-border-none u-btn u-button-style u-hover-none u-none u-text-palette-1-base u-btn-1">Study published in Nanoscale Magazine</a>&nbsp;) which led to this innovation. 
            </p>
            <a href="https://tiendananofix.cl/" class="u-border-2 u-border-grey-dark-1 u-btn u-btn-round u-button-style u-radius-50 u-btn-2">Read More</a>
          </div>
        </div>
        <div class="u-align-center u-carousel-item u-clearfix u-section-5-3">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h3 class="u-text u-text-1">S​1. WO2018122598 - CURCUMIN-LOADED NANOEMULSIONS, METHOD OF MANUFACTURE, AND METHOD OF PREVENTIVE TREATMENT USING THE SAME </h3>
            <img class="u-image u-image-default u-image-1" src="images/Capturadepantalla2022-09-04093607.jpg" alt="" data-image-width="1356" data-image-height="808">
            <h4 class="u-text u-text-2">
              <br>&nbsp;We succesfully patented a method of preparation and manufacturing of an oil-in-water curcumin nanoemulsion as well as its application to prevent metastatic cancer by administering an amount of the nanoemulsion topically to an area of an excised primary tumor, and monitoring any reincidence of metastatic cancer in the excised primary tumor area.
            </h4>
            <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018122598" class="u-border-2 u-border-grey-dark-1 u-btn u-btn-round u-button-style u-radius-50 u-btn-1">Read More</a>
          </div>
        </div>
      </div>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-prev u-text-grey-30 u-block-8612-3" href="#carousel_b0d3" role="button" data-u-slide="prev">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M145.188,238.575l215.5-215.5c5.3-5.3,5.3-13.8,0-19.1s-13.8-5.3-19.1,0l-225.1,225.1c-5.3,5.3-5.3,13.8,0,19.1l225.1,225
                    c2.6,2.6,6.1,4,9.5,4s6.9-1.3,9.5-4c5.3-5.3,5.3-13.8,0-19.1L145.188,238.575z"></path></svg>
        </span>
        <span class="sr-only">Previous</span>
      </a>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-next u-text-grey-30 u-block-8612-4" href="#carousel_b0d3" role="button" data-u-slide="next">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M360.731,229.075l-225.1-225.1c-5.3-5.3-13.8-5.3-19.1,0s-5.3,13.8,0,19.1l215.5,215.5l-215.5,215.5
                    c-5.3,5.3-5.3,13.8,0,19.1c2.6,2.6,6.1,4,9.5,4c3.4,0,6.9-1.3,9.5-4l225.1-225.1C365.931,242.875,365.931,234.275,360.731,229.075z"></path></svg>
        </span>
        <span class="sr-only">Next</span>
      </a>
    </section>
    <section class="u-carousel u-slide u-block-479f-1" id="carousel_71b3" data-interval="5000" data-u-ride="carousel">
      <ol class="u-absolute-hcenter-lg u-absolute-hcenter-md u-absolute-hcenter-xl u-carousel-indicators u-block-479f-5">
        <li data-u-target="#carousel_71b3" class="u-active u-grey-30" data-u-slide-to="0"></li>
        <li data-u-target="#carousel_71b3" class="u-grey-30" data-u-slide-to="1"></li>
        <li data-u-target="#carousel_71b3" class="u-grey-30" data-u-slide-to="2"></li>
        <li data-u-target="#carousel_71b3" class="u-grey-30" data-u-slide-to="3"></li>
        <li data-u-target="#carousel_71b3" class="u-grey-30" data-u-slide-to="4"></li>
        <li data-u-target="#carousel_71b3" class="u-grey-30" data-u-slide-to="5"></li>
      </ol>
      <div class="u-carousel-inner" role="listbox">
        <div class="u-active u-align-center u-carousel-item u-clearfix u-palette-1-dark-2 u-section-6-1">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-default u-title u-text-1">Check my involvment in multiple EU​ actions</h1>
            <p class="u-large-text u-text u-text-variant u-text-2">Research and outreach activities for the European Union’s Horizon 2020 under the Marie Sklodowska Curie grant agreement.&nbsp;<br>
              <br>In particular with the projects:&nbsp; No 777682 (CANCER), SIMICA (852985), 861190 (PAVE) and 952520 (BIOSAFETY).
            </p>
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-palette-5-dark-3 u-section-6-2">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-title u-text-1"> SIMICA&nbsp;Knowledge&nbsp;Transfer Zone&nbsp;h​eld on 28 June 2022<br>
              <br>
            </h1>
            <h4 class="u-text u-text-2"> Gonçalo Bernardes from Ucam, Pablo Lara from LUMC and João Seixas from TargTex presented at the SIMICA&nbsp;Knowledge&nbsp;Transfer Zone in Lisbon. The participants had the opportunity to learn about methods for modification of proteins and extracellular vesicles and how to apply these constructs for biological applications that impact academia and industry.</h4>
            <img class="u-image u-image-default u-image-1" src="images/Simica-transferable-knowledge-SIMICA2-1024x1024.jpg" alt="" data-image-width="1018" data-image-height="665">
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-palette-1-dark-3 u-section-6-3">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-1">Grant writing training for BIOSAFETY on December 9th 2021&nbsp;&nbsp; </h1>
            <img class="u-image u-image-default u-image-1" src="images/descarga.jfif" alt="" data-image-width="718" data-image-height="720">
            <h4 class="u-hidden-xs u-text u-text-2">EU/Horizon Europe funding: How to write a succesfull grant application</h4>
            <p class="u-large-text u-text u-text-variant u-text-3">The aim of the course was to improve the skills of ESRs in writing grant proposal.&nbsp;The course was made for PhD students of the BIOSAFETY and open to ​any interested external attenders<br>
              <br>
              <br>
            </p>
            <p class="u-text u-text-4"> Attendance certificate was released for participants&nbsp;</p>
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-section-6-4">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h2 class="u-text u-text-1">Grant writing training for PAVE on 3rd of November 2021</h2>
            <h4 class="u-text u-text-2">The training objectives were:&nbsp;&nbsp;1) Communicate ​effectively in written research papers;&nbsp;2) Develop written skills required&nbsp;for successful applications for grants and fellowships&nbsp;&nbsp;3) Appreciate potential barriers to successful
scientific writing in different contexts (e.g. papers versus grants).</h4>
            <img class="u-expanded-width-sm u-expanded-width-xs u-image u-image-default u-image-1" src="images/Capturadepantalla222022-09-01164026.jpg" alt="" data-image-width="585" data-image-height="315">
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-white u-section-6-5">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h1 class="u-text u-text-1">SIMICA lecture about extracellular vesicles on May 21th 2021​&nbsp;</h1>
            <img class="u-image u-image-default u-image-1" src="images/SIMICA-lecture-Pablo-Lara2-1024x495.png" alt="" data-image-width="690" data-image-height="444">
            <img class="u-hidden-xs u-image u-image-default u-image-2" src="images/SIMICA-Pablo-Lara-IMmM-5-970x1024.png" alt="" data-image-width="964" data-image-height="768">
            <a href="https://vimeo.com/560909903" class="u-border-2 u-border-hover-palette-1-base u-border-palette-1-base u-btn u-btn-round u-button-style u-hover-palette-1-base u-none u-radius-50 u-btn-1"> Missed it? Watch it here!!</a>
          </div>
        </div>
        <div class="u-carousel-item u-clearfix u-palette-1-dark-3 u-section-6-6">
          <div class="u-clearfix u-sheet u-sheet-1">
            <h2 class="u-text u-text-default-lg u-text-default-xl u-text-1">Participation in CANCER project: Seconded to Sheffield University 2020&nbsp;&nbsp;</h2>
            <img class="u-image u-image-default u-image-1" src="images/IMG_3101-gruppe1.jpg" alt="" data-image-width="630" data-image-height="315">
            <img class="u-image u-image-default u-image-2" src="images/INSIDE_cancerinterview_pablolara-05-a.jpg" alt="" data-image-width="640" data-image-height="315">
            <h4 class="u-text u-text-2">
              <a class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-white u-btn-1" href="https://www.cancer-nemi.eu/EU_Projects/CANCER.nsf/xStart_Basic.xsp?action=openDocument&amp;documentId=EB20C8CECDA490CBC12581590055C9E2"> 20. March 2019&nbsp;Krakow (PO) CANCER Midterm Meeting<br>
              </a>
            </h4>
            <a href="https://www.cancer-nemi.eu/EU_Projects/CANCER.nsf/xStart_Basic.xsp?action=openDocument&amp;documentId=C278C88790CEE1B4C125861B002B3D34" class="u-border-2 u-border-hover-palette-1-base u-border-white u-btn u-btn-round u-button-style u-hover-palette-1-base u-none u-radius-50 u-btn-2"><b>&nbsp;Check out my Interview for the CANCER Project.</b>
            </a>
            <h4 class="u-text u-text-3"> CANCER - Immunotherapy Approaches To Improving Cancer Outcome and Quality of Life (QOL)</h4>
          </div>
        </div>
      </div>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-prev u-text-grey-30 u-block-479f-3" href="#carousel_71b3" role="button" data-u-slide="prev">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M145.188,238.575l215.5-215.5c5.3-5.3,5.3-13.8,0-19.1s-13.8-5.3-19.1,0l-225.1,225.1c-5.3,5.3-5.3,13.8,0,19.1l225.1,225
                    c2.6,2.6,6.1,4,9.5,4s6.9-1.3,9.5-4c5.3-5.3,5.3-13.8,0-19.1L145.188,238.575z"></path></svg>
        </span>
        <span class="sr-only">Previous</span>
      </a>
      <a class="u-absolute-vcenter u-carousel-control u-carousel-control-next u-text-grey-30 u-block-479f-4" href="#carousel_71b3" role="button" data-u-slide="next">
        <span aria-hidden="true">
          <svg class="u-svg-link" viewBox="0 0 477.175 477.175"><path d="M360.731,229.075l-225.1-225.1c-5.3-5.3-13.8-5.3-19.1,0s-5.3,13.8,0,19.1l215.5,215.5l-215.5,215.5
                    c-5.3,5.3-5.3,13.8,0,19.1c2.6,2.6,6.1,4,9.5,4c3.4,0,6.9-1.3,9.5-4l225.1-225.1C365.931,242.875,365.931,234.275,360.731,229.075z"></path></svg>
        </span>
        <span class="sr-only">Next</span>
      </a>
    </section>
    
    
    <footer class="u-align-center u-clearfix u-footer u-grey-80 u-footer" id="sec-8c84"><div class="u-align-left u-clearfix u-sheet u-sheet-1"></div></footer>
    <section class="u-backlink u-clearfix u-grey-80">
      <a class="u-link" href="https://nicepage.com/templates" target="_blank">
        <span>Template</span>
      </a>
      <p class="u-text">
        <span>created with</span>
      </p>
      <a class="u-link" href="https://nicepage.online" target="_blank">
        <span>Best Website Builder</span>
      </a>. 
    </section>
  
</body></html>